| Primary |
| Renal Transplant |
46.8% |
| Heart Transplant |
13.3% |
| Liver Transplant |
11.0% |
| Hypertension |
5.5% |
| Immunosuppression |
4.8% |
| Prophylaxis Against Transplant Rejection |
3.2% |
| Prophylaxis |
3.0% |
| Hyperlipidaemia |
1.5% |
| Infection Prophylaxis |
1.5% |
| Renal Hypertension |
1.4% |
| Lung Transplant |
1.2% |
| Diabetes Mellitus |
1.2% |
| Congenital Cystic Kidney Disease |
0.9% |
| Gastritis Prophylaxis |
0.9% |
| Constipation |
0.8% |
| Hypercholesterolaemia |
0.8% |
| Antifungal Prophylaxis |
0.7% |
| Thrombosis Prophylaxis |
0.6% |
| Transplant |
0.6% |
| Prophylaxis Against Gastrointestinal Ulcer |
0.5% |
|
| Pyrexia |
15.3% |
| Transplant Rejection |
9.1% |
| Vomiting |
8.2% |
| Kidney Transplant Rejection |
7.3% |
| Proteinuria |
5.8% |
| Renal Impairment |
5.1% |
| Pulmonary Embolism |
4.7% |
| Sepsis |
4.7% |
| Interstitial Lung Disease |
4.2% |
| Weight Decreased |
4.0% |
| Renal Failure Acute |
3.8% |
| Pneumonia |
3.6% |
| Liver Transplant Rejection |
3.3% |
| Urinary Fistula |
3.3% |
| Respiratory Failure |
3.1% |
| Thrombocytopenia |
3.1% |
| Oedema Peripheral |
2.9% |
| Renal Tubular Necrosis |
2.9% |
| Urinary Tract Infection |
2.9% |
| Death |
2.7% |
|
| Secondary |
| Renal Transplant |
39.1% |
| Heart Transplant |
27.4% |
| Hypertension |
8.5% |
| Immunosuppression |
3.7% |
| Liver Transplant |
2.5% |
| Hyperlipidaemia |
2.1% |
| Infection Prophylaxis |
1.7% |
| Renal Hypertension |
1.7% |
| Prophylaxis Against Transplant Rejection |
1.6% |
| Cardiac Failure |
1.6% |
| Cardiac Failure Congestive |
1.6% |
| Antifungal Prophylaxis |
1.5% |
| Lung Transplant |
1.2% |
| Prophylaxis |
1.2% |
| Gastritis Prophylaxis |
1.0% |
| Hypercholesterolaemia |
0.9% |
| Cardiovascular Event Prophylaxis |
0.9% |
| Product Used For Unknown Indication |
0.8% |
| Constipation |
0.6% |
| Drug Use For Unknown Indication |
0.5% |
|
| Pyrexia |
11.0% |
| Stomatitis |
9.7% |
| Renal Impairment |
8.7% |
| Subcutaneous Abscess |
7.7% |
| Vomiting |
5.5% |
| C-reactive Protein Decreased |
5.1% |
| Immunosuppressant Drug Level Increased |
5.0% |
| Viral Infection |
4.6% |
| Kidney Transplant Rejection |
4.3% |
| Urinary Tract Infection |
4.1% |
| Dyspnoea |
4.0% |
| Weight Decreased |
3.9% |
| Renal Failure Acute |
3.6% |
| Transplant Rejection |
3.6% |
| White Blood Cell Count Increased |
3.6% |
| Necrosis |
3.3% |
| Renal Tubular Necrosis |
3.2% |
| Tooth Infection |
3.2% |
| Glucose Tolerance Impaired |
3.0% |
| Respiratory Syncytial Virus Infection |
3.0% |
|
| Concomitant |
| Renal Transplant |
19.3% |
| Heart Transplant |
12.8% |
| Product Used For Unknown Indication |
11.7% |
| Drug Use For Unknown Indication |
7.4% |
| Hypertension |
7.4% |
| Immunosuppression |
7.2% |
| Tuberculosis |
5.4% |
| Hepatitis C |
4.3% |
| Liver Transplant |
3.8% |
| Pain |
3.1% |
| Prophylaxis |
3.1% |
| Prophylaxis Against Transplant Rejection |
2.9% |
| Transplant Rejection |
2.2% |
| Clonus |
1.6% |
| Gastritis Prophylaxis |
1.6% |
| Type 2 Diabetes Mellitus |
1.6% |
| Bronchopulmonary Aspergillosis |
1.3% |
| Diabetes Mellitus |
1.1% |
| Dyslipidaemia |
1.1% |
| Hyperparathyroidism Secondary |
1.1% |
|
| Renal Failure Acute |
10.3% |
| Deafness Bilateral |
7.7% |
| Renal Failure |
7.7% |
| Urinary Tract Infection |
7.7% |
| Septic Shock |
6.4% |
| Transplant Rejection |
6.4% |
| Renal Tubular Disorder |
5.1% |
| Sepsis |
5.1% |
| Thrombocytopenia |
5.1% |
| Urosepsis |
5.1% |
| Condition Aggravated |
3.8% |
| Diarrhoea |
3.8% |
| Pyelocaliectasis |
3.8% |
| Pyrexia |
3.8% |
| Renal Impairment |
3.8% |
| Transplant Failure |
3.8% |
| Acute Hepatic Failure |
2.6% |
| Cerebral Haemorrhage |
2.6% |
| Complications Of Transplanted Kidney |
2.6% |
| Drug Ineffective |
2.6% |
|
| Interacting |
| Heart Transplant |
52.1% |
| Epilepsy |
17.5% |
| Prophylaxis |
11.3% |
| Hypertension |
7.1% |
| Renal Transplant |
3.7% |
| Hepatitis C |
2.4% |
| Product Used For Unknown Indication |
1.5% |
| Pain |
1.0% |
| Liver Transplant |
0.8% |
| Acne |
0.6% |
| Aspergillus Infection |
0.3% |
| Convulsion |
0.3% |
| Insomnia |
0.3% |
| Renal Cancer |
0.3% |
| Sedative Therapy |
0.3% |
| Aspergillosis |
0.2% |
| Lung Transplant |
0.2% |
|
| Immunosuppressant Drug Level Increased |
21.2% |
| Drug Interaction |
20.2% |
| Bronchopulmonary Aspergillosis |
9.6% |
| Coronary Artery Stenosis |
9.6% |
| Renal Impairment |
9.6% |
| Vascular Operation |
9.6% |
| Ventricular Extrasystoles |
3.8% |
| Haemolysis |
2.9% |
| Vomiting |
2.9% |
| Hyponatraemia |
1.9% |
| Renal Failure |
1.9% |
| Ventricular Hypertrophy |
1.9% |
| Weight Decreased |
1.9% |
| Herpes Zoster |
1.0% |
| Renal Arteriosclerosis |
1.0% |
| Thrombotic Microangiopathy |
1.0% |
|
